Intelligent Bio Solutions Inc. Announces That DGP Plc Has Selected The Revolutionary Portable Intelligent Fingerprinting Drug Screening System To Enable In-House Drug Testing
Portfolio Pulse from Benzinga Newsdesk
Intelligent Bio Solutions Inc. (INBS) announced that DGP Plc has chosen its Intelligent Fingerprinting Drug Screening System for in-house drug testing. The system offers a non-invasive, rapid method for testing drugs through fingerprint sweat, which is more convenient and less disruptive compared to traditional methods. DGP Plc, a UK construction logistics firm, will use the system for its 450 employees and contractors to enhance safety and productivity. INBS's CEO highlighted the system's flexibility and cost savings for organizations.
January 22, 2024 | 1:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Intelligent Bio Solutions Inc. has partnered with DGP Plc, which will use its fingerprint drug testing system for workplace drug screening. This partnership could enhance INBS's market presence and credibility in the medical technology sector.
The adoption of INBS's drug screening system by DGP Plc is a positive development, indicating market acceptance and potential for increased sales. This could lead to positive investor sentiment and a short-term increase in INBS's stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90